EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Leveraging Proteomics to Explore the Molecular Mechanisms of Primary Tauopathies

Laura Nementzik, Tomas Kavanagh, Sian Genoud, Eleanor Drummond iD

Journal of Neurochemistry · 2025

DOI: 10.1111/jnc.70270 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von Laura Nementzik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia. Hauptthemen laut MEDLINE: Proteomics, Tauopathies, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 164 Literaturangaben. Gefördert von: TDM Foundation, Kennards Hire Foundation, Bluesand Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary tauopathies are progressive neurodegenerative diseases characterised by the deposition of aggregated tau in the brain. The molecular mechanisms underlying tau toxicity and neurodegeneration in these diseases are still poorly understood. Proteomics studies of human primary tauopathy brain tissue are beginning to provide insight into molecular mechanisms involved in disease pathogenesis. Here, we review the current landscape of human brain proteomics in three primary tauopathies: progressive supranuclear palsy, corticobasal degeneration, and Pick's disease. For progressive supranuclear palsy, the most well‐studied primary tauopathy, we provide a combined analysis of bulk proteomic changes in the brain. From this compilation and additional studies using complementary proteomics approaches, we highlight five highly relevant disease mechanisms in primary tauopathies: mitochondrial dysfunction, synaptic impairment, autophagy and endolysosomal dysfunction, RNA and RNA‐binding protein dysregulation, and iron dyshomeostasis. We discuss how each of these mechanisms participates in primary tauopathy pathogenesis and suggest recommendations for future proteomics studies that will advance our understanding of these diseases. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsTauopathiesBrainHumansAnimalsSupranuclear Palsy, Progressivetau Proteins

Stichwörter der Autor:innen

RNA‐binding proteinsautophagycorticobasal degenerationferritin light chainmitochondriapick's diseaseprogressive supranuclear palsyproteomicssynapsetauopathy

Substanzen

tau Proteins

Autor:innen und Institutionen

  • Neuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.
  • Brain and Mind Centre, University of Sydney, Camperdown, New South Wales, Australia.

ORCID-Profile: Eleanor Drummond

Förderung

  • TDM Foundation
  • Kennards Hire Foundation
  • Bluesand Foundation

Zitieren

APA

Nementzik, L., Kavanagh, T., Genoud, S., & Drummond, E. (2025). Leveraging Proteomics to Explore the Molecular Mechanisms of Primary Tauopathies. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70270

Vancouver

Nementzik L, Kavanagh T, Genoud S, Drummond E. Leveraging Proteomics to Explore the Molecular Mechanisms of Primary Tauopathies. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70270

BibTeX
@article{Nementzik2025,
  author = {Nementzik, Laura and Kavanagh, Tomas and Genoud, Sian and Drummond, Eleanor},
  title = {Leveraging Proteomics to Explore the Molecular Mechanisms of Primary Tauopathies},
  journal = {Journal of Neurochemistry},
  year = {2025},
  doi = {10.1111/jnc.70270}
}
Kostenlos starten →